Attenuation of influenza-like symptomology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment

A 1997 study that observed people taking 600 mg of NAC twice daily for six months had a significantly lower probability of contracting influenza, with 79% of the placebo group developing illness compared to 25% of the NAC group.